4.17 The Chinese School is about to open grandly and look forward to working with you to develop clinical treatment of chronic hepatitis B...

2019 Gather Chinese Wisdom to Lead the Road to Clinical Cure for Chronic Hepatitis B

In 2019, with the rapid development of the clinical cure for chronic hepatitis B, the "First Chronic Hepatitis B Clinical Cure Summit and China Summit Forum Summit" set sail smoothly.

2020 Gather Chinese Wisdom to Write a New Chapter in the Clinical Cure of Chronic Hepatitis B

In 2020, the outbreak of the new crown epidemic did not stop us from moving forward.

Gather Chinese wisdom in 2021 to open up a new future for chronic hepatitis B clinical cure

On April 17 this year, we will simultaneously open the "3rd Chronic Hepatitis B Clinical Cure Summit and China Summit Forum" online and offline, to undertake the "Leading Road" and "New Chapter" theme of the previous two conferences.

Live time

April 17, 2021 (this Saturday)

8:20-18:00

Watch live or watch back

--Identify the QR code--

01

Focus on the clinical cure of chronic hepatitis B, and look at the frontiers together

Since the clinical cure of chronic hepatitis B has entered a rapid development stage in 2019, more and more studies have been published on clinical cure at home and abroad.

02

Chinese practice and Chinese thinking on the clinical cure of chronic hepatitis B

China has been at the forefront of the world in the more than ten years of clinical exploration of chronic hepatitis B.

In order to comprehensively improve the clinical cure rate of chronic hepatitis B, there have been many scientific questions surrounding the clinical cure, such as how to treat non-dominant patients? Is there a better treatment strategy for poor nucleoside response or hypoviremia? Researchers in my country have new ideas and new ideas, including how to change the treatment strategy, how to appropriately extend the course of treatment, and how to adopt a treatment strategy with a target and indefinite course of treatment to improve the chance of clinical cure.

At that time, Professor Lu Fengmin will also host a round-table discussion on the cure strategy of chronic hepatitis B.

03

Dig deep into hot and difficult issues, and break each one

In order for more patients to achieve clinical cure, there are still many problems to be solved.

Special populations are the key populations that need attention in the treatment of chronic hepatitis B.

The clinical cure rate of children with chronic hepatitis B is higher than that of adults, and has reached a higher level.

The burden of liver cancer in my country is serious, and more than 90% of the cases are caused by HBV infection.

Antiviral therapy can effectively improve the progress of liver histology in patients with chronic hepatitis B and effectively reduce the risk of liver cancer.

Meeting schedule